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Background: Only few studies have analyzed the pharmaceutical workforce in primary healthcare centers, and a global 
recommendation calls for better understanding of the trends that shape workforce development and capacity.  
Objective: To analyze the distribution of the pharmaceutical workforce in primary healthcare centers in the national health system 
[Sistema Único de Saúde (SUS)] in Brazil.  
Methods: The study was conducted using data from the National Survey on Access, Use and Promotion of Rational Use of Medicines in 
Brazil. Secondary data referring to the socioeconomic indicators of each municipality were obtained from national public databases. 
Data stratification in geographic regions was considered, and data on workers in the management of the municipal pharmaceutical 
services and medicines dispensing centers were analyzed. Crude and adjusted prevalence ratios were calculated by Poisson regression 
in the study investigating the factors associated with low and high-density pharmacists per 10,000 inhabitants.  
Results: The results showed that most Brazilian municipalities have a rate of 1 or more pharmacist per 10,000 inhabitants in primary 
healthcare public facilities, with a higher concentration of pharmacists in small municipalities. Even in Brazilian municipalities with 
lower economic capacity, the conditions of access to medicines and pertinent information on medicines were directly related to the 
number of pharmacists available in these centers. 
Conclusions: This study showed a high number of pharmacists in the public health system. The higher density of pharmacists in 
primary healthcare public facilities correlated to increased access to medicines information and better municipal social development. 
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INTRODUCTION 
Strengthening the workforce emerges as a topic of growing 
global interest to ensure the sustainability of public health 
programs and policies.1 Main challenges and trends 
affecting workforce planning include the country's 
economic status, empowerment, gender balance, and 
especially the distribution of the workforce.2,3 
In many countries, pharmacists are considered to be the 
most accessible healthcare professionals. As the third most 
skilled, and in many cases the first point of contact within 
the healthcare system, pharmacists are an essential 
component of the healthcare workforce.4,5 They are 
fundamental to achieve the goal of equitable access and 
rational drug use, a key objective of universal health 
coverage.6 Pharmacists are playing an increasing role in 
primary healthcare centers (PHC), fulfilling a growing range 
of roles and responsibilities, especially for improving access 
and the appropriate use of medicines.7-10  
In Brazil, among the more than 210,000 registered 
pharmacists (around 10/10,000 inhabitants), more than 
30,000 pharmacists work in PHC and are employed by the 
SUS. This number grew by 75% from 2008 to 2013.11,12 
Pharmacists in Brazil play a key role in the organization of 
the healthcare system because, unlike most countries, 
medicines dispensed by the public system are mostly 
financed, purchased, distributed, and dispensed by public 
health facilities. In many of the Brazilian municipalities, the 
management of the supply chain and of the pharmaceutical 
services is performed by pharmacists. In 33% of PHC, 
pharmacists work in dispensing and clinical services in 
interprofessional teams, although all health centers provide 
medicines to patients.11-13 Some studies have questioned 
what is the ideal pharmacist workforce in PHC, pointing out 
that there is no magic number for the proportion of 
pharmacists.10 A report from the International 
Pharmaceutical Federation (FIP)  provided data on the 
pharmaceutical workforce in a number of countries.4,14,15 
However, data on the workforce capacity and distribution 
of pharmacists in public health services are lacking for 
many countries including Brazil. This lack of reliable data 
makes it difficult to adequately plan and develop the 
healthcare workforce needed for the adequately delivery of 
medicines and pharmaceutical services.6  
PHC is an important approach to achieve the Sustainable 
Development Goals for universal access to health through 
affordable, comprehensive, and appropriate healthcare.16 
Research indicates that PHC-consolidated countries and 
regions would have lower costs and better health 
outcomes.8,17  
Since its creation in 1990, the SUS has made consistent 
progress towards delivering universal and comprehensive 
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health care to the Brazilian population, helping to reduce 
inequalities in health-care access and the achievement of 
better outcomes. The implementation of the SUS marked a 
shift in the model of health care through the rapid 
expansion of comprehensive PHC and the development of 
health networks for mental health services, hospitals, 
emergency care, and specialized outpatient services.18 The 
right of access to medicines is ensured by ubiquitous public 
health care centers.19 Purchase and distribution of 
medicines in public health centers represent about 16% of 
the expenditure of the health system.20  
The objective of the study was to analyze the 
pharmaceutical workforce in PHC in Brazil based on the 
conditioning factors, access to medicines and information 
on the use of medicines, and the distribution of 
pharmacists in public health facilities. 
 
METHODS 
Description of study population 
In Brazil, PHC is organized and provided by the 
municipalities. Therefore, most of the workforce at this 
level is hired by municipal governments, with an estimate 
of over 44,000 PHC in 5,570 municipalities in the country, 
most of which dispense medicines free of charge.21  
Municipalities must plan, purchase and distribute essential 
medicines but funding is shared with federal and state 
government. Each municipality must have the 
infrastructure to govern the National Pharmaceutical Policy 
at this level, including access to medicines.22 The 
population of this study is formed by pharmacists hired to 
work in municipal public health services. 
National Survey on Access, Use and Promotion of Rational 
Use of Medicines (PNAUM) 
PNAUM was established by the Ordinance of the Brazilian 
Ministry of Health no. 2077 on 17 September 2012 and 
performed in 2014-2015. 23 PNAUM aimed to characterize 
the organization of pharmaceutical services in the PHC of 
SUS, focusing on the access and promotion of the rational 
use of medicines, as well as to identify and discuss factors 
that affect the consolidation of pharmaceutical policy in the 
PHC in the municipalities. This was the first nationwide 
research focused on access and use of medicines in Brazil. 
23, 24 PNAUM researched the management processes at 
municipal level, the PHC infrastructure, processes of the 
pharmaceutical services, the patients access to medicines 
and pharmaceutical services, availability of medicines, 
physicians’ opinions and legal aspects of the services 
provision. 24 It was conducted by a pool of Brazilian public 
funded universities. 
The study populations were stratified by geographic region: 
North, Northeast, South, Southeast, and Midwest, and 
these strata constituted the study fields. Three samples 
were randomly selected including municipalities 
(managers), healthcare facilities (local managers, 
pharmacists, physician and technicians), and patients in 
each region. Data were collected from the observation of 
1,175 pharmacies located into PHC, 507 face-to-face and 
telephone interviews with managers of pharmaceutical 
services of the municipal level, and face-to-face interviews 
with 285 pharmacists and 854 technicians in charge of 
medicines dispensing; 1,558 physician and 1,800 patients of 
the PHC included in the sample. The data collection used 
pre-coded questionnaires (collected on tablet computers) 
composed of closed-ended questions, developed by the 
research team and piloted in a different sample of 
municipalities. The data were collected by trained 
researchers, specifically hired for this project.24,25 
A full description of the research methodology is available 
in Álvares et al. and the report published by the Ministry of 
Health.24,25 The PNAUM project were approved by the 
National Research Ethics Committee (Opinion 
398.131/2013).25 
To represent the density of the pharmaceutical workforce 
in PHC, the measurement described in the FIP global 
pharmaceutical workforce reports was adopted as a 
parameter, where density was expressed as the number of 
pharmacists per 10,000 inhabitants.26 This simple approach 
was the most commonly used metric for description and 
planning.27 
The absolute number of pharmacists working in public 
healthcare services by municipalities, the distribution of 
pharmacists by gender and function performed 
(coordinating and assisting functions), education, type of 
employment, and the number of healthcare units in the 
sample municipalities were collected. 
In addition, access to medicines was obtained according to 
information from patients interviewed by PNAUM, using 
the following variable: In these last three months, how 
often did you get the medicines you were looking for at SUS 
public pharmacies?.24 
Based on the patient’s responses, access was categorized 
as full access, partial access, or impaired access. Full access 
was attributed to responses from patients who claimed to 
obtain all necessary medications in the last three months. 
Partial or impaired access was answered by patients who 
were not able to obtain the medicines they sought at any 
time, sometimes, or rarely, in the last three months. 
Patients were also asked if they had received information 
or guidance on the use of medicines at the PHC: When you 
pick up medicines at SUS public pharmacies, do the 
employees who deliver the medicines provide information 
or guidance on how to use them?.24 There is no 
standardized format for providing information and 
guidance for the use of medicines in health centers. For this 
reason, any form of information provision was considered 
as information provided. Two categories were defined: 
received information, and little or no information (if the 
patient answered that receive information only sometimes 
or never receive). 
Access to the requested medicines and receiving 
information and guidance on their use were the variables 
available in the PNAUM database and which were 
considered in this study as positive results for patient care. 
In addition to the PNAUM variables, secondary data on the 
socioeconomic indicators of each municipality were 
included: Gross Domestic Product (GDP), per capita 
income, population size (small municipalities were those 
with a population <20,000 inhabitants [70.4% of the 
Brazilian municipalities]; medium size-population, between 
Faraco EB, Guimarães L, Anderson C, Leite SN. The pharmacy workforce in public primary healthcare centers: promoting access 
and information on medicines. Pharmacy Practice 2020 Oct-Dec;18(4):2048.  
https://doi.org/10.18549/PharmPract.2020.4.2048 
 www.pharmacypractice.org (eISSN: 1886-3655 ISSN: 1885-642X)  
© Pharmacy Practice and the Authors 
3  
>20,000 and <50,000 inhabitants [24.5% of the Brazilian 
municipalities]; and large size-population, >100 thousand 
inhabitants [5.1% of the Brazilian municipalities]); and the 
absolute number of public PHC units in each municipality of 
the sample classified by establishment type.28 These data 
were collected in the online database available at the 
Department of Informatics portal of the Ministry of Health, 
accessed by the website www2.datasus.gov.br. 
The Municipal Human Development Index (MHDI) was also 
included. The MHDI aggregates three important 
dimensions of human development represented by health, 
education, and income, which were grouped by the 
geometric mean, resulting in a number ranging from 0 to 1. 
The closer the number was to 1, the greater the human 
development of a healthcare unit: federal, municipal, 
metropolitan region or human development unit, i.e. a HDI 
of <0.550 is considered low human development; medium 
human development was between 0.550-0.699; high 
human development, between 0.700-0.799; and very high 
human development, >0.800.29  
The data related to the MHDI were collected in the online 
database available at the United Nations Development 
Program portal, accessed at www.atlasbrasil.org.br. 
Statistical analysis 
The analyses of the data collected by PNAUM were 
performed using SPSS (IBM Corp, Armonk, USA) version 25, 
using the CSPLAN command set, where commands and 
sample weights were applied to adjust the cluster design, 
as described in Álvares et al.
25
 
Descriptive statistical methods were weighted to adjust the 
demographic distribution of the PNAUM sample to the 
distribution of the Brazilian population, along with bivariate 
tests.25 Pearson's chi-square test was performed to 
determine the relationship between the number of 
available pharmacists, the employment ratio, the weekly 
workload, PHC pharmaceutical practices, and each region 
of the country. Poisson regressions were performed using 
STATA software version 13 (Stata Corp LP, College Station, 
Texas, USA) using the proprietary svy command set for 
complex sample analysis. The variable was dichotomized in 
municipalities with <1 pharmacist per 10,000 inhabitants 
and municipalities with 1 or more pharmacist per 10,000 
inhabitants. This made it possible to better understand the 
relationship between the variables studied. The adopted 
significance level was 5%. 
 
RESULTS  
The global average of pharmacists for every 10,000 
inhabitants in public services offered at PHC in Brazil was 
1.76 (95%CI 1.61: 1.90). The difference between the 
regions, South, 2.11 (95%CI 1.82: 2.41) and Northeast, 1.19 
(95%CI 0.94: 1.44) was almost 1 pharmacist per 10,000 
population. There was a higher prevalence of municipalities 
with ≥1 pharmacist per 10,000 inhabitants (Figure 1). 
No differences were observed between the prevalence of 
pharmacists by sex, age group, or weekly workload in 
municipalities with a pharmacists rate per 10,000 
Inhabitants (PRI) of 1 or over when compared to those in 
municipalities with a PRI of <1. Table 1 presents data 
regarding the characterization of the pharmaceutical 
workforce in Brazil considering PRI. 
Two roles played by pharmacist in PHC were highlighted: 
the management activities of the pharmaceutical services, 
the supply chain and the dispensing of medicines. In 95.7% 
(95%CI 91.5: 97.9) of the municipalities, the management 
of pharmaceutical services in the healthcare department 
Table 1. Sample characterization and comparison between municipalities with less and more than 1 pharmacist per 10,000 inhabitants 
  
  
Pharmacists /10000 inhabitants Poisson regressions Univariate 
Less than 1 
% [CI95%] 
1 or more 
% [CI95%] 
p-value  RP [CI 95%] p-value  
Sex      
Female 38.6 [32,7- 44,9] 61.4 [55.1- 67.3] 0.925 1.01 [0.85 - 1.20] 0.925 
Male 39.1 [31,2- 47,7] 60.9 [52.3- 68.8]  1  
Age Range      
Up to 30 years 37.0 [29,5- 45,3] 6.0 [54.7- 70.5] 0.614 1.82 [0.39 - 8.45] 0.443 
31 to 49 years 38.2 [31,6- 45,3] 61.8 [54.7- 68.4]  1.79 [0.39 - 8.28] 0.458 
50 to 59 years 45.9 [28,2- 64,8] 54.1 [35.2- 71.8]  1.56 [0.33 - 7.51] 0.576 
60 or more 65.4 [15,4- 95,1] 34.,6 [4.9- 84.6]  1  
Employment      
Server Competed  33.6 [27,4- 40,3] 66.4 [59.7- 72.6] 0.002 1.48 [1.13 - 1.94] 0.004 
Commissioned 55.9 [44,9- 66,4] 44.1 [33.6- 55.1]  1  
Other 35.0 [25,4- 46,1] 65.0 [53.9- 74.6]  2.10 [1.61 - 2.74] <0.001 
Weekly workload      
Up to 30 hours 42.6 [34,4- 51,2] 57.4 [48.8- 65.6] 0.216 1.11 [0.93 - 1.33] 0.244 
more than 30 hours 36.3 [30,5- 42,5] 63.7 [57.5- 69.5]   1  
Figure 1. Pharmacists rate per 10,000 inhabitants by region of 
brazil 
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was the responsibility of a pharmacist. Only 43.8% (95%CI 
36.2: 51.7) of PHC units had a pharmacist during all hours 
of operation. When this percentage was stratified by the 
region of the country, the Northeast and North, had the 
lower proportions of full-time pharmacists on their work 
team. The ecological design of the sample using Poisson 
regressions demonstrated significant differences between 
the analyzed variables related to PRI, as shown in Table 2. 
It was observed that 75.4% of the municipalities with a 
population size up to 25,000 inhabitants and 94.7% of the 
smaller municipalities with up to two PHC had a PRI of >1, 
while in 80% of municipalities with population over 100,000 
inhabitants (83.3% of the capital city, and in 100% of the 
largest municipalities in each region) the PRI was <1.  
When relating PRI to socioeconomic indicators, significant 
differences were highlighted in the municipalities with GDP 
up to USD 35,300, of which 83.5% had a PRI of 1 or over. In 
contrast, 74% of municipalities with GDP over USD 199,000 
had a PRI of <1. 
Regarding per capita income, there were no significant 
variations between municipalities and PRI. When grouping 
the MHDI into two categories (namely, lower and higher), 
significant differences were observed between the studied 
groups. In 68.2% of the municipalities within the highest 
MHDI, the PRI is 1 or over. 
Regarding the receipt of information or guidance on 
medicines use, in 78.9% (p<0.001) of municipalities with a 
PRI of 1 or over, patients claimed to always receive 
information. On the other hand, users in 54.4% of the 
municipalities claimed to receive little or no information, 
PRI was <1. In the analysis of access to medicines, no 
statistically significant differences were observed, although 
it was found that 79.1% of municipalities with a PRI of 1 or 
over had full access to medicines. Among patients who 
indicated partial or impaired access, the percentage of 
municipalities with a PRI of 1 or over decreased to 58.2% 
(Table 3). 
The density of the pharmaceutical workforce in PHC in 
Table 2. Ecological design – Comparison between groups of pharmacists and the variables studied 
  Pharmacists /10000 inhabitants Poisson Regression Univariate 
  
Less than 1 
% [CI95%] 
1 or more 
% [CI95%] 
p-value  RP [CI95%] p-value  
Population Size      
Up to 25,000 inhabitants 24.6 [20.0 - 29.9] 75.4 [70.1 - 80] <0.001 3.77 [1.49- 9.55] 0.005 
25,000 to 100,000 inhabitants 83.1 [72.6 - 90.1] 16.9 [9.9 - 27.4]  0.85 [0.29- 2.45] 0.759 
Over 100,000 inhabitants 80.0 [55.8 - 92.7] 20.0 [7.3 - 44.2]  1  
Group to which the municipality belongs (sample)      
Capitals 83.3 [62.3 - 93.8] 16.7 [6.2 - 37.7] <0.001   
0.5% higher in the region 100.0 [100.0 - 100.0] 0 [0 - 0]    
Smaller municipalities 5.3 [2.2 - 12.6] 94.7 [87.4 - 97.8]    
MHDI      
0-0.699 42.8 [36.6 - 49.3] 57.2 [50.7 - 63.4] 0.031 1  
0.7-0.800 31.8 [24.9 - 39.7] 68.2 [60.3 - 75.1]  1.19 [1.02- 1.39] <0.001 
Region      
North 51.3 [41 - 61.4] 48.7 [38.6 - 59] <0.001 1.18 [0.84- 1.66] 0.333 
Midwest 31.2 [22.7 - 41.0] 68.8 [59.0 - 77.3]  1.67 [1.24- 2.24] 0.001 
South 26.8 [18.9 - 36.5] 73.2 [63.5 - 81.1]  1.76 [1.33- 2.37] <0.001 
Southeast 27.5 [19.7 - 36.9] 72.5 [63.1 - 80.3]  1.76 [1.32- 2.34] <0.001 
Northeast 58.7 [47.7 - 69.0] 41.3 [31 - 52.3]  1  
HC tax      
up to 3.23 54.3 [42.5 - 65.7] 45.7 [34.3 - 57.5] 0.001 1  
3.24 – 4.29 43.2 [33.7 - 53.4] 56.8 [46.6 - 66.3]  1.24 [0.91 - 1.71] 0.178 
4.30 – 6.30 40.8 [31.6 - 50.6] 59.2 [49.4 - 68.4]  1.30 [0.95 - 1.77] 0.098 
over 6.30 24.2 [16.8 - 33.6] 75.8 [66.4 - 83.2]  1.66 [1.25 - 2.21] 0.001 
Per capita income (quartile)      
up to USD 4200 47.4 [38.1 - 56.9] 52.6 [43.1 - 61.9] 0.086 1  
USD 4200 -  USD 7530 34.1 [24.8 - 44.7] 65.9 [55.3 - 75.2]  1.25 [0.99 - 1.59] 0.063 
USD 7530 -  USD 12597 33.4 [24.6 - 43.6] 66.6 [56.4 - 75.4]  1.27 [1.00 - 1.60] 0.047 
over  USD 12597 34.4 [25.2 - 45] 65.6 [55 - 74.8]  1.25 [0.98 - 1.58] 0.067 
GDP (quartile)      
up to  USD 35300 16.5 [10.1 - 25.9] 83.5 [74.1 - 89.9] <0.001 3.21 [2.13 - 4.85] <0.001 
USD 35300 -  USD 79700 27.9 [20 - 37.5] 72.1 [62.5 - 80]  2.77 [1.83 - 4.22] <0.001 
USD 79700 -  USD 199000 50.7 [41.2 - 60.1] 49.3 [39.9 - 58.8]  1.90 [1.21 - 2.98] 0.005 
over  USD 199,000 74.0 [62.5 - 83] 26 [17.0 - 37.5]  1.0  
GDP=Gross Domestic Product; HC=healthcare unit; MHDI=Municipal Human Development Index.  
Table 3. Primary healthcare workforce indicators 
 Pharmacists /10000 inhabitants 
Less than 1; % [CI95%] 1 or more; % [CI95%] p-value  
Access to medicines    0.091 
Full access 20.9 [7.8 - 45.3] 79.1 [54.7 - 92.2]  
Partial / Impaired access 41.8 [33.8 - 50.2] 58.2 [49.8 - 66.2]  
Receiving information   <0.001 
Received information 21.1 [13.2 - 31.9] 78.9 [68.1 - 86.8]   
Little or no information 54.4 [43.6 - 64.9] 45.6 [35.1 - 56.4]  
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Brazil through the association between the healthcare unit 
rate per 10,000 populations and the PRI is shown in Figure 
2. In all regions, the healthcare unit rate was predominantly 
higher than the PRI, the Northeast was 1.18 (95%CI 0.94: 
1.43) and North was 1.51 (95%CI 1.18: 1.84). 
 
DISCUSSION 
The results show that the most of the Brazilian 
municipalities have a rate of 1 or higher pharmacist per 
10,000 inhabitants working in public system PHC. However, 
they also show an uneven distribution of the 
pharmaceutical workforce in public PHC in Brazil. The 
Brazilian public health system helped to achieve a 
narrowing of health inequalities with improvements in 
coverage and access to healthcare across the country, but 
large variations remain between municipalities regarding 
the infrastructure, human resources, management 
capacity, and access to effective healthcare services.12,18 
The differences in pharmaceutical workforce can be 
observed, in this study, between the different geographical 
regions, the different population sizes, and the different 
socioeconomic conditions of the municipalities. 
Unlike the pattern of concentration of pharmacists and 
other healthcare professionals in private services, in public 
PHC the highest density of pharmacists is found in small 
municipalities. It is evident that the larger municipalities 
also have a lower rate of healthcare units and serve larger 
populations, while the small municipalities have more 
healthcare units serving smaller populations and higher 
concentration of pharmacists. This scenario results in a 
higher rate of pharmacists in small municipalities, that have 
an also a higher rate of healthcare units per population. 
Therefore, in Brazil, the population living in smaller 
municipalities is more likely to have better access to 
pharmacists in PHC services than those living in larger 
cities. Small municipalities represent 45% of all Brazilian 
municipalities, where 208,494,900 inhabitants live.28 So 
these results have great relevance for the planning and 
evaluation of pharmaceutical services in the country. 
In addition to being smaller in population, municipalities 
with a higher prevalence of a PRI of 1 or over, also have a 
higher MHDI. It is noteworthy that 3,110 (72%) 
municipalities with up to 25,000 inhabitants are in the 
range between medium to very high human development. 
Moreover, it is evident that the municipalities with a PRI of 
1 or over have a lower GDP. In larger municipalities, GDP 
rises due to the big business concentrated in large cities, 
since GDP in Brazil is calculated through the share with 
which each municipality contributes. In the municipalities 
with a PRI 1 or over, GDP was lower and the MHDI showed 
better results. This results support the understanding that 
the MHDI indicates the development resulted from social 
policies and is not limited to economic growth.29 In this 
scenario, the investment in hiring of pharmacists makes up 
the framework for the development of local public policies 
in these municipalities. 
The density of the pharmacy workforce per capita varies 
considerably across countries and regions and generally 
correlates with population size and country-level economic 
indicators. The economic situation of a country is directly 
related to the per capita health expenditure and 
pharmaceutical density.4 The results here show that, in PHC 
public funded services, PRI is related to investments in 
social policies and economic development and not 
necessarily pure economic index.  
The study also revealed an important difference in the 
density of pharmacists between the geographic regions, 
with the municipalities with lower PRI being concentrated 
in the North and Northeast regions of the country. These 
regions have historically been the ones with the greatest 
social and economic problems, which are reflected in the 
worst health indicators and greatest weaknesses in the 
organization of their public services. In them are 
concentrated the municipalities with the lowest MHDI. But 
these are also the regions that received attention from 
public policies in the last decade and, for this reason, 
showed significant growth in PHC and health 
professionals.12 
Figure 2. Pharmacists workforce density and healthcare units by region of 
brazil 
Faraco EB, Guimarães L, Anderson C, Leite SN. The pharmacy workforce in public primary healthcare centers: promoting access 
and information on medicines. Pharmacy Practice 2020 Oct-Dec;18(4):2048.  
https://doi.org/10.18549/PharmPract.2020.4.2048 
 www.pharmacypractice.org (eISSN: 1886-3655 ISSN: 1885-642X)  
© Pharmacy Practice and the Authors 
6  
Between 2008 and 2013, the population of the country 
grew at a rate of 6%; healthcare units grew 12%; and the 
number of accredited professionals registered in PHC grew 
24%. This data reveals a significant expansion of the PHC 
capacity, an increase in the number of jobs, and the 
possibility of developing interprofessional collaboration.  
Nurses and physician grew 42% and 17% in the same 
period, while other accredited professionals presented 
much higher growth, with rates above 70%, as in the case 
of pharmacists, physiotherapists, nutritionists, physical 
education professionals, and occupational therapists.12 In 
this scenario, pharmacists have been engaged in 
collaborative activities in the PHC: 39.8% claim they 
participate in PHC team meetings, and more than 30% 
claim they are engaged in prevention of diseases and 
health promotion activities.30 Although only 29% claim that 
they perform clinical services, their effective participation 
in primary health care services has the potential to 
generate positive health results, as has been shown in 
several studies.31 
The high prevalence of total access to medicines in Brazil 
was demonstrated by PNAUM in a previous publication. 
Access rates were 94.3%, 5.2%, and 0.5% for total, partial 
and null access, respectively.32 This positive outcome is 
understood to be as a result of incentives to public health 
policies, investments and financial resources, 
standardization, and procurement of medicines in recent 
years.19 The results of this study also show that full access 
to medicines is more often reported among PHC patients in 
municipalities with a PRI of 1 or over. Total access occurred 
in 79.1% of municipalities with 1 or more pharmacists per 
10,000 inhabitants. Among patients who indicated partial 
and impaired access, the percentage of municipalities with 
a PRI of 1 or over decreased to 58.2%. Although not 
representing a statistically significant difference, the higher 
proportion may raise hypotheses for further investigation. 
In addition, the indicator on information about the use of 
the medicines received by the patients revealed that in 
78.9% of municipalities with a PRI of 1 or over, patients 
always received information compared to 45.6% of 
municipalities with a PRI of 1 or over receiving little or no 
information. 
Globally, countries with the lowest number of pharmacists 
per capita are likely to have less access to medicines, as 
well as the provision of pharmaceutical services and 
advice.4 In agreement, it is argued that the increase in PRI 
or the higher density of pharmacists in PHC becomes an 
important factor related to improving people access to 
medicines and information about their treatment. The 
results also suggest that the employment of pharmacists in 
PHC in Brazil is a well-established trend in municipal health 
management policy. In most municipalities with PRI 1 or 
over, pharmacists are hired by public tender and have 
stability in their function. Considering that the number of 
pharmacists hired to work in public PHC in Brazil grew by 
75% in 5 years.11,12 It can be inferred that the good 
performance of SUS in providing access to essential 
medicines in the last decade and the increase in the density 
of pharmacists in PHC are conditions that go together.32 
The greater number of pharmacists employed in a 
municipality may also represent evidence of greater 




The study shows that there are positive results related to a 
higher rate of pharmacists in the SUS. In municipalities with 
a PRI 1 or over, public PHC patients are more likely to 
receive information about the medicines they receive, with 
a possible trend of greater access to medicines among 
these municipalities. The PHC's pharmaceutical workforce 
scenario in Brazil is characterized by a higher concentration 
of pharmacists in small municipalities with higher MHDI, 
mainly in the South and Southeast regions of the country. It 
is essential that the healthcare system invest in the 
continuous growth of the pharmaceutical workforce to 
meet the demands of this level of health care and achieve 
better health outcomes. 
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